We searched publications in PubMed using the search terms ”schizophr*[ti]” or ”psychosis[ti]” or ”psychotic[ti]”. We used 1558 English language reviews and meta-analyses published in the past 5 years. These reports were downloaded into an Endnote library file and scanned for relevance with regard to the topics selected for this review. Further focused searches on PubMed were then done on the selected topics.
SeminarSchizophrenia
Introduction
Although the precise societal burden of schizophrenia is difficult to estimate, because of the wide diversity of accumulated data and methods employed, cost-of-illness indications uniformly point to disquieting human and financial costs.1 Schizophrenia does not just affect mental health; patients with a diagnosis of schizophrenia die 12–15 years before the average population, with this mortality difference increasing in recent decades.2 Thus, schizophrenia causes more loss of lives than do most cancers and physical illnesses. Although some deaths are suicides, the main reason for increased mortality is related to physical causes, resulting from decreased access to medical care and increased frequency of routine risk factors (poor diet, little exercise, obesity, and smoking).2
Section snippets
Diagnosis
Identification of delusions and hallucinations in psychosis is not difficult, but their classification has not been simple. Psychosis is not exclusive to schizophrenia and occurs in various diagnostic categories of psychotic disorder (panel). The criteria used to distinguish between these different categories of psychotic disorder are based on duration, dysfunction, associated substance use, bizarreness of delusions, and presence of depression or mania. However, the resulting diagnostic
Epidemiology
A systematic review of epidemiological data indicates that, if the diagnostic category of schizophrenia is considered in isolation, the lifetime prevalence and incidence are 0·30–0·66% and 10·2–22·0 per 100 000 person-years, respectively.17 Rates vary three-fold depending on the diagnostic definition of schizophrenia that is used: a narrow definition, including patients with illness duration of at least 6 months, age below 45 years, and negative symptoms has lower rates than a broad definition
Gene and environment interplay
Vulnerability for schizophrenia is partly genetic. Twin studies suggest that the syndrome has heritability estimates of around 80% (compared with ∼60% for osteoarthritis of the hip and 30–50% for hypertension). Despite this genetic association, the identification of specific molecular genetic variation has not been easy. Modification of diagnostic criteria and uncertainty about the natural phenotype of psychosis are likely to have hampered progress in this regard.
Recent findings have suggested
Prognosis
The traditional clinical and societal view of schizophrenia is of a debilitating and deteriorating disorder with poor outcome. However, most patients now live independently outside the hospital and the typical duration of admission is short (a few weeks). Although most patients need some degree of formal or informal financial and daily-living support, the perspective now is one of recovery, where the patient takes an active role in the development of new meaning and purpose while growing beyond
Pathophysiology
Since the advent of modern neuroimaging techniques, the number of studies of the pathophysiological changes of schizophrenia has dramatically increased, with more than 1000 reports published in the past 10 years. Structural brain imaging studies have shown a subtle, almost universal, decrease in grey matter, enlargement of ventricles, and focal alteration of white matter tracts.96, 97, 98
Neurochemical imaging studies to test the dopamine hypothesis of schizophrenia with 18F-dopa and 11
Clinical management
Diagnosis of schizophrenia is made by reference to the criteria in DSM-IV and ICD-10. Even though these are clinical criteria, diagnosis can be achieved with acceptably high inter-rater reliability and compares well with diagnostic reliability in the rest of medicine. Unfortunately, no objective test exists for this diagnosis. Although several biological abnormalities have been reproduced (eg, abnormally large ventricles, abnormal dopamine concentration, and altered P300), they are not
Prevention
Because psychotic disorders occur in young people and disrupt educational and social development, early intervention is crucial and could favourably affect long-term prognosis. A few studies have assessed the use of specialised early interventions for first-episode psychotic disorder patients with encouraging results in the first year;136 follow-up, however, suggests that the benefits of early intervention might be lost after 5 years.137
Whether early intervention can be extended to at-risk
Cognition
Almost 100 years ago when schizophrenia was first defined in its current form, it was called dementia praecox, the focus being on the intellectual deterioration that accompanied the syndrome. In the following years, the focus shifted to the psychosis, the delusions, and the hallucinations as the cardinal features of the illness, perhaps because they are easy to identify and greatly affect functioning and society. However, during the past 10 years, there has been a resurgence of interest in the
Conclusions
In the 100 years that we have known the diagnosis of schizophrenia, its definition has swung between a biological illness, a psychological dysfunction, and a social construct. The advances of genetics, epidemiology, imaging, and pharmacology now allow us to put these perspectives together (figure 4). A clear genetic susceptibility exists in schizophrenia; however, what one inherits is not the illness, but altered brain development, shared partly with developmental disorders, such as autism, and
Search strategy and selection criteria
References (152)
- et al.
Schizophrenia
Lancet
(2004) - et al.
Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: a population-based study
Lancet
(2009) Madness explained: why we must reject the Kraepelinian paradigm and replace it with a ‘complaint-orientated’ approach to understanding mental illness
Med Hypotheses
(2006)- et al.
Male gender is associated with deficit schizophrenia: a meta-analysis
Schizophr Res
(2001) - et al.
Delta-9-tetrahydrocannabinol effects in schizophrenia: implications for cognition, psychosis, and addiction
Biol Psychiatry
(2005) - et al.
Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review
Lancet
(2007) - et al.
Paternal ages below or above 35 years old are associated with a different risk of schizophrenia in the offspring
Eur Psychiatry
(2007) - et al.
Heritability of brain morphology related to schizophrenia: a large-scale automated magnetic resonance imaging segmentation study
Biol Psychiatry
(2008) - et al.
Is the P300 wave an endophenotype for schizophrenia? A meta-analysis and a family study
Neuroimage
(2005) - et al.
Neurocognitive function and outcome in first-episode schizophrenia: a 10-year follow-up of an epidemiological cohort
Schizophr Res
(2003)
Brain morphology in first-episode schizophrenia: a meta-analysis of quantitative magnetic resonance imaging studies
Schizophr Res
Meta-analysis of diffusion tensor imaging studies in schizophrenia
Schizophr Res
Meta-analysis of gray matter anomalies in schizophrenia: application of anatomic likelihood estimation and network analysis
Biol Psychiatry
Neurobiology of dopamine in schizophrenia
Int Rev Neurobiol
A systematic review of mortality in schizophrenia: is the differential mortality gap worsening over time?
Arch Gen Psychiatry
The Roscommon Family Study. II. The risk of nonschizophrenic nonaffective psychoses in relatives
Arch Gen Psychiatry
A twin study of genetic relationships between psychotic symptoms
Am J Psychiatry
Rethinking psychosis: the disadvantages of a dichotomous classification now outweigh the advantages
World Psychiatry
Are psychotic psychopathology and neurocognition orthogonal? A systematic review of their associations
Psychol Bull
Structure and course of positive and negative symptoms in schizophrenia
Arch Gen Psychiatry
Seeking verisimilitude in a class: a systematic review of evidence that the criterial clinical symptoms of schizophrenia are taxonic
Schizophr Bull
A systematic review and meta-analysis of the psychosis continuum: evidence for a psychosis proneness-persistence-impairment model of psychotic disorder
Psychol Med
Dimensions and the psychosis phenotype
A salience dysregulation syndrome
Br J Psychiatry
Schizophrenia: yesterday's concept
Eur Psychiatry
Acceptable terminology and subgroups in schizophrenia: an exploratory study
Soc Psychiatry Psychiatr Epidemiol
Renaming schizophrenia: a Japanese perspective
World Psychiatry
Schizophrenia: a concise overview of incidence, prevalence, and mortality
Epidemiol Rev
Sex and schizophrenia: effects of diagnostic stringency, and associations with and premorbid variables
Br J Psychiatry
Lifetime prevalence of psychotic and bipolar I disorders in a general population
Arch Gen Psychiatry
Influence of diagnostic classification on gender ratio in schizophrenia—a meta-analysis of youths hospitalized for psychosis
Soc Psychiatry Psychiatr Epidemiol
Obstetric complications and schizophrenia: historical and meta-analytic review
Am J Psychiatry
Higher risk of offspring schizophrenia following antenatal maternal exposure to severe adverse life events
Arch Gen Psychiatry
Prenatal infection as a risk factor for schizophrenia
Schizophr Bull
Prenatal nutritional deficiency and risk of adult schizophrenia
Schizophr Bull
The antecedents of schizophrenia: a review of birth cohort studies
Schizophr Bull
Premorbid IQ in schizophrenia: a meta-analytic review
Am J Psychiatry
Development of social functioning in preschizophrenia children and adolescents: a systematic review
Psychol Bull
Evidence for early-childhood, pan-developmental impairment specific to schizophreniform disorder: results from a longitudinal birth cohort
Arch Gen Psychiatry
A population-based cohort study of premorbid intellectual, language, and behavioral functioning in patients with schizophrenia, schizoaffective disorder, and nonpsychotic bipolar disorder
Am J Psychiatry
A longitudinal study of premorbid IQ score and risk of developing schizophrenia, bipolar disorder, severe depression, and other nonaffective psychoses
Arch Gen Psychiatry
Psychosis and place
Epidemiol Rev
Schizophrenia and urbanicity: a major environmental influence—conditional on genetic risk
Schizophr Bull
Schizophrenia and migration: a meta-analysis and review
Am J Psychiatry
Incidence of schizophrenia in ethnic minorities in London: ecological study into interactions with environment
BMJ
Ethnic density of neighborhoods and incidence of psychotic disorders among immigrants
Am J Psychiatry
The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: implications for psychosis
Neuropsychopharmacology
The acute effects of synthetic intravenous Δ9-tetrahydrocannabinol on psychosis, mood, and cognitive functioning
Psychol Med
An experimental study of catechol-o-methyltransferase Val158Met moderation of delta-9-tetrahydrocannabinol-induced effects on psychosis and cognition
Neuropsychopharmacology
Cannabis, the mind and society: the hash realities
Nat Rev Neurosci
Cited by (1801)
The role of SIRT3 in mediating the cognitive deficits and neuroinflammatory changes associated with a developmental animal model of schizophrenia
2024, Progress in Neuro-Psychopharmacology and Biological PsychiatryProteomic profiling in the progression of psychosis: Analysis of clinical high-risk, first episode psychosis, and healthy controls
2024, Journal of Psychiatric ResearchIncidence, prevalence, and mortality of schizophrenia from 2016 to 2020 in Shandong, China
2024, Psychiatry ResearchDRD4 VNTR 4/4 homozygosity as a genetic biomarker for treatment selection in patients with schizophrenia
2024, Asian Journal of Psychiatry